Journals / Viral Hepatitis Journal / 2016 / Cilt: 22 - Sayı: 2

Chronic Viral Hepatitis in Human Immunodeficiency Virus-infected Patients

İnsan Bağışıklık Yetmezlik Virüsü Enfeksiyonu Olan Hastada Kronik Viral Hepatit

Pages
39–42
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hepatitis C cure can be achieved with directly acting antiviral agents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Infectious diseases physicians taking care of human immunodeficiency virus-infected patients should investigate for the presence of chronic hepatitis caused by hepatitis B and hepatitis C virus infections.
📊
Key Findings & Data:This is important as chronic viral hepatitis progresses more rapidly to end-stage liver disease in human immunodeficiency virus-infected patients.
💡
Conclusion & Impact:Hepatitis C cure can be achieved with directly acting antiviral agents.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Infectious diseases physicians taking care of human immunodeficiency virus-infected patients should investigate for the presence of chronic hepatitis caused by hepatitis B and hepatitis C virus infections. This is important as chronic viral hepatitis progresses more rapidly to end-stage liver disease in human immunodeficiency virus-infected patients. Once diagnosed, there are effective drugs for the treatment chronic viral hepatitis. Tenofovir containing anti-retroviral therapy effectively suppresses hepatitis B replication. Hepatitis C cure can be achieved with directly acting antiviral agents.

Özet

İnsan bağışıklık yetmezlik virüsü ile enfekte hastalarda kronik hepatit B virüsü (HBV) ve hepatit C virüsü (HCV) enfeksiyonları da araştırılmalıdır. Bu hastalarda kronik viral hepatitler daha hızlı ilerler ve siroz daha çabuk gelişir. Tanı konulduktan sonra kronik viral hepatitler için etkin tedavi verilebilir. HBV'nin replikasyonunu tenofovir içeren anti-retroviral tedaviler ile baskılamak mümkündür. Doğrudan etkili antiviral ilaçların geliştirilmesiyle HCV enfeksiyonunun sağaltımı mümkün hale gelmiştir.

🔖

Cite This Article

SİLİ, U., TEKİN, A., KORTEN, V. (2016). Chronic Viral Hepatitis in Human Immunodeficiency Virus-infected Patients. Viral Hepatitis Journal, Cilt: 22 - Sayı: 2, 39–42. https://ajindex.com/articles/332679

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. EACS. European Guidelines for treatment of HIV-positive adults. October 2015; Available from: http://www.eacsociety. org/guidelines/eacs-guidelines/eacs-guidelines.html
  2. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. January 28, 2016; Available from:
  3. El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol 2011;4:5-10
  4. Spradling PR, Richardson JT, Buchacz K, Moorman AC, Brooks JT; HIV Outpatient Study (HOPS) Investigators. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007. J Viral Hepat 2010;17:879-886
  5. Aydin OA, Yemisen M, Karaosmanoglu HK, Sargin F, Gunduz A, Ceylan B, Mete B, Ozgunes N, Sevgi DY, Ozaras R, Tabak F.bak, Low Prevalence of Hepatitis C Virus Infection Among HIV-Positive Patients: Data From a Large-Scale Cohort Study in Istanbul, Turkey. Hepat Mon 2014;14:18128
  6. Hahné SJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Laar Mv. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis 2013;13:181
  7. Spradling PR, Richardson JT, Buchacz K, Moorman AC, Finelli L, Bell JT; HIV Outpatient Study Investigators. Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007. J Acquir Immune Defic Syndr 2010;53:388-396
  8. Arends JE, Lieveld FI, Boeijen LL, de Kanter CT, van Erpecum KJ, Salmon D, Hoepelman AI, Asselah T, Ustianowski A. Natural history and treatment of HCV/HIV coinfection: Is it time to change paradigms? J Hepatol 2015;63:1254-1262
  9. Yemisen M, Aydın OA, Gunduz A, Ozgunes N, Mete B, Ceylan B, Karaosmanoglu HK, Yildiz D, Sargin F, Ozaras R, Tabak F. Epidemiological profile of naive HIV-1/AIDS patients in Istanbul: the largest case series from Turkey. Curr HIV Res 2014;12:60- 64
  10. Dokuzoguz B, Korten V, Gökengin D, Fincanci M, Yildirmak T, Kes UN, Tasdelen Fisgin N, Inan D, Eraksoy H, Akalin H. Transmission route and reasons for HIV testing among recently diagnosed HIV patients in HIV-TR cohort, 2011-2012. J Int AIDS Soc 2014;17(4 Suppl 3):19595
  11. European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012;57:167-185